Gapping down
Other news:
- SKYE -62.2% (reports Topline CBeyond phase 2a data from nimacimab monotherapy and combination clinical trial)
- DFLI -21.7% (prices offering of 20,000,000 shares of common stock at $1.25 per share for gross proceeds of approximately $25.0 mln)
- QUBT -12.1% (prices offering of 37,183,937 shares of common stock for gross proceeds of $750 million)
- FITB -3.8% (Comerica to be acquired by Fifth Third Bancorp (FITB) in all-stock transaction)
- SYRE -1.8% (announces poster presentations at United European Gastroenterology Week (UEGW) 2025)
- TIC -1.1% (announces $250 million private placement)
- ORKA -0.8% (files for 39,425,806 share common stock offering by selling shareholders; files for $500 mln mixed securities shelf offering; also $200 mln common stock sales agreement with TD Securities as sales agent)